Target intelligence / Profile preview

Ocular surface epithelial cell apoptosis

Molecular classification
Cellular process
01

Overview

Apoptosis of ocular surface epithelial cells refers to the programmed cell death of corneal and conjunctival epithelial cells, a process pivotal for the maintenance and pathology of the ocular surface[1][6]. This form of cell death is involved in normal tissue homeostasis but can be accelerated in response to environmental triggers such as ultraviolet radiation, hyperosmolarity (dry eye), or pharmacological exposure (corticosteroids)[1][2][4]. Mechanistically, apoptosis is driven by activation of potassium channels leading to K⁺ efflux, caspase activation, and mitochondrial signaling, and is detectable by molecular biomarkers such as TUNEL staining and caspase cleavage[2][4][6]. Dysregulated or excessive apoptosis contributes to diseases like dry eye and keratoconjunctivitis sicca and therefore represents an indirect therapeutic target[3][6]. However, because this is a process rather than a discrete molecular entity, anti-apoptotic therapies target upstream signaling pathways or environmental triggers rather than the apoptotic machinery itself[2][3][4].

Other names
epithelial cell apoptosis of ocular surfacecorneal epithelial apoptosisconjunctival epithelial cell apoptosis
02

Mechanism of action

Activation of K⁺ channels leading to K⁺ efflux and cell death upon stress (e.g., UV, hyperosmolarity). Glucocorticoid-induced apoptosis via intrinsic pathway and mitochondrial ROS. Inflammatory cytokine increase, caspase activation.

03

Biological functions

ApoptosisCell deathHomeostasis of ocular surface tissues
04

Disease associations

Dry eye disease (keratoconjunctivitis sicca)InflammationOcular trauma/UV damageSjögren’s syndrome
05

Safety considerations

Excessive apoptosis can cause corneal ulceration, delayed epithelial healing, and visual impairmentInduction by therapeutic agents (e.g., glucocorticoids) might paradoxically worsen ocular surface diseaseInflammation and immune activation may further drive cell death
06

Interacting drugs

Prednisolone

2 more in the full profile.

07

Biomarkers

TUNEL staining for DNA fragmentationCaspase-3, -8, -9 activationPoly(ADP-ribose) phosphate (PARP) cleavageAltered barrier function/protein expression in corneal and conjunctival epithelium

Beyond the preview

Go deeper on Ocular surface epithelial cell apoptosis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface epithelial cell apoptosis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call